Feb 9 (Reuters) - Biogen Idec Inc:
* Sees total research and development expense in 2010 being 24 percent- 27
percent of total revenue - SEC filing
* Sees selling, general and administrative expenses increasing in 2010 versus
2009
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) (For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Sees total research and development expense in 2010 being 24 percent- 27
percent of total revenue - SEC filing
* Sees selling, general and administrative expenses increasing in 2010 versus
2009
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) (For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.